Skip to main content

Solid Biosciences Inc.

SLDB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001707502

No open-market purchases or sales by Solid Biosciences Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Solid Biosciences Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of SLDB: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders125116−9
Shares79.2M82.8M+3.63M (+4.6%)
Value$293.2M$403.4M+$110.2M (+37.6%)

New holders (26)

Institutions that held Solid Biosciences Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to SLDB in Q2 2025
InstitutionSharesValue% of portfolio
Ally Bridge Group (NY) LLC724,000$3.53M2.93%
Sectoral Asset Management Inc421,580$2.05M1.36%
Armistice Capital, LLC400,000$1.95M0.07%
Bollard Group LLC361,660$1.76M0.04%
Blair William & Co165,700$807.0K0.00%
Wellington Management Group LLP135,761$661.2K0.00%
Sphera Funds Management Ltd.50,190$244.4K0.06%
Polar Asset Management Partners Inc.43,500$211.8K0.01%
MetLife Investment Management40,085$195.2K0.00%
Wealthedge Investment Advisors, LLC30,855$150.3K0.06%
Manufacturers Life Insurance Company, The24,409$118.9K0.00%
Dynamic Technology Lab Private Ltd22,982$112.0K0.02%
Mariner, LLC19,414$94.5K0.00%
Voya Investment Management LLC18,248$88.9K0.00%
ProShare Advisors LLC16,431$80.0K0.00%
SG Americas Securities, LLC13,086$64.0K0.00%
Creative Planning11,801$57.5K0.00%
Pallas Capital Advisors LLC11,042$53.8K0.00%
Martingale Asset Management L P10,220$49.8K0.00%
Raymond James Financial Inc2,835$13.8K0.00%
Allworth Financial LP411$2.00K0.00%
UMA Financial Services, Inc.312$1.52K0.00%
Essential Partners LLC263$1.28K0.00%
Parkside Financial Bank & Trust135$6580.00%
Rothschild Investment LLC75$3650.00%
Clearstead Advisors, LLC9$440.00%

Sold out (35)

Institutions that held Solid Biosciences Inc. at the end of Q1 2025 and filed for Q2 2025 without it.